Nektar Therapeutics Inc. logo

Nektar Therapeutics Inc. (NKTR)

Market Open
8 Dec, 18:41
NASDAQ (CM) NASDAQ (CM)
$
57. 74
+0.84
+1.48%
$
1.34B Market Cap
- P/E Ratio
- Div Yield
209,260 Volume
-0.72 Eps
$ 56.9
Previous Close
Day Range
56.54 58.93
Year Range
6.45 66.92
Want to track NKTR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Nektar Therapeutics (NKTR) Q2 2024 Earnings Call Transcript

Nektar Therapeutics (NKTR) Q2 2024 Earnings Call Transcript

Nektar Therapeutics (NKTR) Q2 2024 Earnings Call Transcript

Seekingalpha | 1 year ago
Nektar's (NKTR) Q2 Earnings Lag Estimates, Revenues Top

Nektar's (NKTR) Q2 Earnings Lag Estimates, Revenues Top

Nektar (NKTR) reports a wider-than-expected loss in the second quarter of 2024 while revenues beat estimates. Stock falls in after-hours trading.

Zacks | 1 year ago
Nektar Therapeutics (NKTR) Reports Q2 Loss, Tops Revenue Estimates

Nektar Therapeutics (NKTR) Reports Q2 Loss, Tops Revenue Estimates

Nektar Therapeutics (NKTR) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.27 per share a year ago.

Zacks | 1 year ago